Arguments for a two-dose yellow fever vaccination regimen in travellers

Andreas Neumayr^{1

2}, Cornelia Stähelin³, Esther Kuenzli^{1

2}, Christoph Hatz^{1

2}

Affiliations

¹ Department of Medicine, Swiss Tropical and Public Health Institute, P.O. Box, Socinstrasse 57, Basel, Switzerland.
² University of Basel, Basel, Switzerland.
³ Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Comment

Andreas Neumayr et al. J Travel Med. 2019.

. 2019 Sep 2;26(6):taz004.

doi: 10.1093/jtm/taz004.

Andreas Neumayr^{1

2}, Cornelia Stähelin³, Esther Kuenzli^{1

2}, Christoph Hatz^{1

2}

¹ Department of Medicine, Swiss Tropical and Public Health Institute, P.O. Box, Socinstrasse 57, Basel, Switzerland.
² University of Basel, Basel, Switzerland.
³ Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

No abstract available

Comment on

Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers.
Lindsey NP, Horiuchi KA, Fulton C, Panella AJ, Kosoy OI, Velez JO, Krow-Lucal ER, Fischer M, Staples JE. Lindsey NP, et al. J Travel Med. 2018 Jan 1;25(1):10.1093/jtm/tay108. doi: 10.1093/jtm/tay108. J Travel Med. 2018. PMID: 30346562 Free PMC article.